Insulet PODD Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $302.8M+22.5% | $247.1M+0.4% | $246.2M+4.3% | $236.1M-41.3% | $402.2M-3.8% | ||
| $94.9M+5.0% | $90.4M+3.3% | $87.5M+0.8% | $86.8M+3.7% | $83.7M+3.6% | ||
| $65.8M+4.9% | $62.7M+0.5% | $62.4M-2.2% | $63.8M-13.0% | $73.3M+5.8% | ||
| $619.3M+8.8% | $569.3M+6.7% | $533.5M+3.4% | $516.1M+27.0% | $406.4M-5.5% | ||
| $203.6M+6.3% | $191.6M+74.0% | $110.1M-1.0% | $111.2M-3.4% | $115.1M-7.8% | ||
| -$234.8M-5.4% | -$222.7M-61.5% | -$137.9M-1.2% | -$136.2M+1.2% | -$137.8M+5.7% | ||
| $359.6M+503% | $59.6M0.0% | $59.6M+98.0% | $30.1M— | —— | ||
| —— | —— | —— | —— | $440.7M— | ||
| $888.3M-15.6% | $1.05B0.0% | $1.05B+94.3% | $541.5M+230% | $163.9M— | ||
| -$1.19B-100% | -$595.3M-9.5% | -$543.6M-514% | -$88.5M— | —— | ||
| -$802.7M-238% | -$237.3M-63.4% | -$145.2M-148% | $300.6M-43.5% | $531.9M+113% | ||
| $415.7M+10.1% | $377.7M-10.8% | $423.4M+4.6% | $404.9M+39.0% | $291.3M-4.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Insulet generate?
- Insulet (PODD) generated $619.3M in operating cash flow over the trailing twelve months.
- What is Insulet's free cash flow?
- After $203.6M of capital expenditures, Insulet's free cash flow was $415.7M over the trailing twelve months, up 42.7% year over year.
- Where does Insulet's cash flow data come from?
- Every line is extracted from Insulet's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
